Toronto Zoo welcomes a female pygmy hippo calf born to 20-year-old Kindia, highlighting the species' endangered status and the zoo's conservation role.
A Penn State study finds honey bees fed diets high in polyunsaturated fatty acids show a 90% survival rate after pesticide exposure, compared to less than 50% for those on saturated or monounsaturated fat diets, highlighting nutrition's role in enhancing resilience.
Australia's latest health report shows cancer survival rates have significantly improved over 30 years. However, experts are concerned by falling childhood vaccination rates, leading to increased cases of measles, diphtheria, and whooping cough.
Research at California's Topaz Solar Farms and California Valley Solar Ranch shows that solar facilities, with predator-proof fencing and panels providing cover, offer an unexpected refuge for the endangered San Joaquin kit fox, improving survival and reproductive rates.
Endangered San Joaquin kit foxes are finding refuge in California's Topaz Solar Farms and California Valley Solar Ranch. Specially designed fencing and solar panel structures provide protection from predators and space for denning and breeding, boosting survival rates.
Bengaluru's Development Minister Krishna Byre Gowda expressed dismay over the ineffectiveness of the Animal Birth Control program, questioning the marginal reduction in stray dogs despite spending Rs 100 crore. He also questioned the fate of 20 lakh saplings planted over two decades, with only 9 lakh trees accounted for.
UN warns US sanctions on Cuba cause spike in infant mortality and child cancer deaths due to lack of medical supplies, despite US claims humanitarian aid is exempt.
Cancer claims 10 million lives annually, with varying deadliness. New drugs show promise for pancreatic and head/neck cancers, and precision medicine is advancing. However, a global shortfall of 100 million healthcare workers by 2050 and treatment delays are critical issues. Worryingly, cancer rates are rising in those under 50, linked to environmental factors.
An experimental drug, GRWD5769, has shown promise in early trials by shrinking tumors by at least 30% in six common cancer types. The drug works by preventing cancer cells from hiding from the immune system, making immunotherapy treatments more effective.
AstraZeneca's experimental breast cancer drug camizestrant faced a setback as a U.S. FDA advisory panel voted 6-3 against approval, citing concerns over the SERENA-6 trial design. The Phase 3 trial showed a 56% reduction in disease progression or death, but panel members weren't convinced early switching improved long-term survival. Shares fell 2% in morning trading, though analysts noted the drug's efficacy wasn't dismissed and the issue shouldn't impact AstraZeneca's $80 billion 2030 sales goal.
NHS struggling to cope with record numbers, which Cancer Research UK says puts progress on survival rates at riskThe number of people in the UK being diagnosed with cancer has reached a record high, with one person diagnosed every 80 seconds, a report reveals.Cancer Research UK found that more than 403,000 people were being diagnosed with the disease each year, largely due to a growing and ageing population, as people are more likely to develop cancer as they get older. Continue reading...
